| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| Although 17 phenyl trinor PGE 2 ( EP 1 and EP 3 ) and PGI 2 ( IP ) had some activity , it occurred at a nonselective dose ( 10 ( 4 ) mol / l ) . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| The stable PGI 2 analogues , iloprost and cicaprost , both activate the PGI 2 receptor ( IP ) and iloprost , additionally , bind to the EP 1 subtype . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| In this study , we have mapped the chromosomal positions of the human genes that encode the PGE 2 receptor subtypes ( PTGER 1 , PTGER 2 , and PTGER 3 ) , the PGF 2 alpha receptor ( PTGFR ) , the PGI 2 receptor ( PTGIR ) , and the TXA 2 receptor ( TBXA2R ) using in situ hybridization . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| Because prostaglandins ( PGs ) have an important role in autoregulation of retinal blood flow , we compared the effects of PGE 2 , PGF 2 alpha , carbacyclin ( PGI 2 analogue ) , and U 46619 ( thromboxane analogue ) , as well as that of agonists for the three different PGE 2 receptor subtypes , 17 phenyl trinor PGE 2 ( EP 1 ) , butaprost ( EP 2 ) , and M & B 28 , 767 ( EP 3 ) , on the retinal vasculature of newborn and adult pigs , using isolated eyecup preparations . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| Putative EP 1 and / or TP receptor selective antagonists had no effect on the responses to PGI 2 , cPGI 2 or PGE 2 in the three preparations studied . 6 . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| Administration of nonselective COX inhibitor ibuprofen or COX 2 inhibitor nimesulide every 8 h for 24 h to newborn rats and pigs reduced prostaglandin levels and caused comparable reductions in nNOS mRNA , protein , and activity to levels of adults ; COX inhibitor induced changes were prevented by cotreatment with PGE 2 analog , 16 , 16 dimethyl PGE 2 , and agonist for the EP 3 receptor of PGE 2 , sulprostone , but not by PGI 2 analog carbaprostacyclin , PGD 2 , EP 1 receptor agonist 17 phenyl trinor PGE 2 , and EP 2 agonist butaprost . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| All prostanoid receptor agonists , except butaprost , contracted the tissues concentration dependently ; the rank order of potency ( U 46619 > sulprostone > PGE 2 > PGF2alpha > PGD 2 = PGI 2 ) suggests the presence of TP and EP 1 and EP 3 receptors on the circular smooth muscle cells . . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| In the vasculature , activation by PGI 2 of IP and EP 1 prostanoid receptors elicits vasodilatation ( via cAMP dependent signaling ) and vasoconstriction , respectively . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| The effects of capsaicin and mucosal acidification on gastric HCO 3 ( ) secretion were compared in wild type and prostacyclin ( PGI 2 ) IP receptor or prostaglandin E receptor EP 1 or EP 3 knockout C57BL / 6 mice as well as rats . ^^^ |
|
| Interacting proteins: O14684 and P34995 |
Pubmed |
SVM Score :0.0 |
| Prostanoids exert their biological actions through binding to eight specific membrane receptors ; the four subtypes EP 1 to EP 4 for PGE 2 ; DP for PGD 2 ; FP for PGF 2 ; IP for PGI 2 ; and TP for thromboxane A 2 . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| Although 17 phenyl trinor PGE 2 ( EP 1 and EP 3 ) and PGI 2 ( IP ) had some activity , it occurred at a nonselective dose ( 10 ( 4 ) mol / l ) . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| In this study , we have mapped the chromosomal positions of the human genes that encode the PGE 2 receptor subtypes ( PTGER 1 , PTGER 2 , and PTGER 3 ) , the PGF 2 alpha receptor ( PTGFR ) , the PGI 2 receptor ( PTGIR ) , and the TXA 2 receptor ( TBXA2R ) using in situ hybridization . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| The stable PGI 2 analogues , iloprost and cicaprost , both activate the PGI 2 receptor ( IP ) and iloprost , additionally , bind to the EP 1 subtype . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| Because prostaglandins ( PGs ) have an important role in autoregulation of retinal blood flow , we compared the effects of PGE 2 , PGF 2 alpha , carbacyclin ( PGI 2 analogue ) , and U 46619 ( thromboxane analogue ) , as well as that of agonists for the three different PGE 2 receptor subtypes , 17 phenyl trinor PGE 2 ( EP 1 ) , butaprost ( EP 2 ) , and M & B 28 , 767 ( EP 3 ) , on the retinal vasculature of newborn and adult pigs , using isolated eyecup preparations . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| Putative EP 1 and / or TP receptor selective antagonists had no effect on the responses to PGI 2 , cPGI 2 or PGE 2 in the three preparations studied . 6 . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| Administration of nonselective COX inhibitor ibuprofen or COX 2 inhibitor nimesulide every 8 h for 24 h to newborn rats and pigs reduced prostaglandin levels and caused comparable reductions in nNOS mRNA , protein , and activity to levels of adults ; COX inhibitor induced changes were prevented by cotreatment with PGE 2 analog , 16 , 16 dimethyl PGE 2 , and agonist for the EP 3 receptor of PGE 2 , sulprostone , but not by PGI 2 analog carbaprostacyclin , PGD 2 , EP 1 receptor agonist 17 phenyl trinor PGE 2 , and EP 2 agonist butaprost . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| All prostanoid receptor agonists , except butaprost , contracted the tissues concentration dependently ; the rank order of potency ( U 46619 > sulprostone > PGE 2 > PGF2alpha > PGD 2 = PGI 2 ) suggests the presence of TP and EP 1 and EP 3 receptors on the circular smooth muscle cells . . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| In the vasculature , activation by PGI 2 of IP and EP 1 prostanoid receptors elicits vasodilatation ( via cAMP dependent signaling ) and vasoconstriction , respectively . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| The effects of capsaicin and mucosal acidification on gastric HCO 3 ( ) secretion were compared in wild type and prostacyclin ( PGI 2 ) IP receptor or prostaglandin E receptor EP 1 or EP 3 knockout C57BL / 6 mice as well as rats . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| Prostanoids exert their biological actions through binding to eight specific membrane receptors ; the four subtypes EP 1 to EP 4 for PGE 2 ; DP for PGD 2 ; FP for PGF 2 ; IP for PGI 2 ; and TP for thromboxane A 2 . ^^^ |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P34995 and O14684 |
Pubmed |
SVM Score :0.0 |
| NA |
|